Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    11323729 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Treatment for Anxiety in Children
Conditions: Obsessive-Compulsive Disorder;   Anxiety Disorders;   Generalized Anxiety Disorder;   Social Phobia;   Separation Anxiety
Intervention: Drug: Fluvoxamine
2 Recruiting Vilazodone for Separation Anxiety Disorder
Condition: Separation Anxiety Disorder
Interventions: Drug: Vilazodone;   Drug: Placebo
3 Completed Treatment of Youth With ADHD and Anxiety
Conditions: Attention Deficit Hyperactivity Disorder;   Anxiety, Separation;   Social Phobia;   Generalized Anxiety Disorder
Interventions: Drug: methylphenidate;   Drug: fluvoxamine
To Top

† Indicates status has not been verified in more than two years